"Anomalous" THY-1(+) killer cells in allogeneic and F1-anti-parental mixed leukocyte culture. Relation to natural killer cells and allospecific cytotoxic T lymphocytes
Open Access
- 1 August 1982
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 156 (2) , 385-403
- https://doi.org/10.1084/jem.156.2.385
Abstract
Anomalous killer cells are Thy-1(+) blasts that are cytolytic to the natural killer (NK)-sensitive lymphoma YAC-1, and that can be detected early (day 3-4) in the period preceeding the allospecific cytotoxic T lymphocyte (CTL) response in (CBA x A)F1 {arrow} C57B1 mixed leukocyte culture (MLC). We have investigated the origin and nature of anomalous killing (AK), with special emphasis on its relation to NK-and allospecific CTL-activity. AK was shown to be distinct from the previously described "NK(c)-cells" induced by cultivation in fetal calf serum (FCS)-supplemented medium when these two reactivities were examined in parallel. AK was detected in either FCS- or normal mouse serum (NMS)-supplemented allogeneic MLC, indicating that the response was not dependent on mitogenic or antigenic properties of heterologous serum. In addition to several H-2-incompatible combinations, AK was also observed in an Mls-incompatible (but H-2 compatible) and two F(1)- antiparental MLC responder/stimulator combinations. AK cells showed a similar selectivity pattern to NK cells, as demonstrated in cold target inhibition and direct cytotoxicity assays using variant or interferon-modulated YAC-1 cells with low expression of NK target structures. The AK-cells were NK- 1.2(-/weak). Thy-l.2(+), although they seem to be derived from non-adherent radiosensitive cells which are closely related, if not identical, to NK-cells (NK-1.2(+). Thy-l.2(-/weak)), as they could not be readily induced in responder populations with low NK-activity but normal allospecific CTL potential. Conversely, an in vivo thymectomy protocol or treatment of normal spleen cells with monoclonal anti-Thy-1.2 + C reduced the allospecific CTL response drastically but did not affect the AK response. Anomalous killers were not observed when MLC were prepared with responder as well as stimulator cells devoid of mature T cells. In such a combination, the AK response could be partially restored by the addition of irradiated +/nu (but not nu/nu) responder cells to the cultures. When normal (non-nude) spleen cells were used as responders, induction of AK did not require the presence of T cells in the stimulator population, whereas the removal of adherent and phagocytic cells from stimulators abrogated the response.Keywords
This publication has 21 references indexed in Scilit:
- CELLS MEDIATING GRAFT REJECTION IN THE MOUSE II. THE LY PHENOTYPES OF CELLS PRODUCING TUMOR ALLOGRAFT REJECTIONTransplantation, 1982
- Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.The Journal of Experimental Medicine, 1981
- Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.The Journal of Experimental Medicine, 1981
- A simplified method for the production of murine T-cell growth factor free of lectinJournal of Immunological Methods, 1981
- Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.The Journal of Experimental Medicine, 1980
- In vitro growth of murine T cellsCellular Immunology, 1980
- T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.The Journal of Experimental Medicine, 1980
- Long term culture of tumour-specific cytotoxic T cellsNature, 1977
- Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donorsInternational Journal of Cancer, 1972
- TREATMENT OF PRIMARY FIBROSARCOMA IN THE RAT WITH IMMUNE LYMPHOCYTESThe Lancet, 1964